Literature DB >> 33756509

Assessment of retinal microvascular health by optical coherence tomography angiography among persons with HIV.

Lauren F Collins1,2, Jessica G Shantha3, Peter L Nesper4, Anandi N Sheth1,2, Amani A Fawzi4, Steven Yeh3,5, Ighovwhera Ofotokun1,2.   

Abstract

Microvasculopathy may link HIV-related chronic inflammation and premature multimorbidity. In this proof-of-concept study, we used optical coherence tomography angiography (OCTA) to evaluate the retina as a convenient assessment of microvascular health among persons with HIV (PWH) undergoing surveillance ophthalmic care at Emory from 2018 to 2021. Among patients with longstanding HIV, OCTA identified microvascular abnormalities even among eyes without clinical retinal disease. Retinovascular evaluation by OCTA is a feasible, noninvasive technique for assessing microvasculopathy among PWH.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 33756509      PMCID: PMC8172530          DOI: 10.1097/QAD.0000000000002890

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.632


  3 in total

1.  Development of a Novel Retina-Based Diagnostic Score for Early Detection of Major Depressive Disorder: An Interdisciplinary View.

Authors:  Xiao Liu; Shunkai Lai; Shisi Ma; Hong Yang; Lian Liu; Guocheng Yu; Shuming Zhong; Yanbin Jia; Jingxiang Zhong
Journal:  Front Psychiatry       Date:  2022-05-19       Impact factor: 5.435

2.  Performance Assessment of Two Different Approaches of Measuring Skeletonized Radial Peripapillary Capillary Vessel Density in Glaucoma Patients.

Authors:  Yiqin Guo; Yunxiao Sun; Xueyuan Zhang; Ningli Wang
Journal:  Front Med (Lausanne)       Date:  2022-03-16

3.  Macular Changes Observed on Optical Coherence Tomography Angiography in Patients Infected With Human Immunodeficiency Virus Without Infectious Retinopathy.

Authors:  Kui-Fang Du; Xiao-Jie Huang; Chao Chen; Wen-Jun Kong; Lian-Yong Xie; Hong-Wei Dong; Wen-Bin Wei
Journal:  Front Med (Lausanne)       Date:  2022-04-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.